NCT04627818 Diagnostic, Therapeutic and Reproductive Aspects of Patients With Mullerian Anomalies
| NCT ID | NCT04627818 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Ghent |
| Condition | Mullerian Anomaly of Uterus, Nec |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,500 participants |
| Start Date | 2021-01-01 |
| Primary Completion | 2050-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,500 participants in total. It began in 2021-01-01 with a primary completion date of 2050-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to get a better understanding of the clinical implications (including reproductive problems and obstetric complications), appropriate diagnostic tools and correct surgical treatment of Mullerian anomalies.
Eligibility Criteria
Inclusion Criteria: * women with a uterus * presence of a mullerian variation * Maximum age 45y Exclusion Criteria: * women without a uterus * aged \>45y
Contact & Investigator
Tjalina Hamerlynck
PRINCIPAL INVESTIGATOR
University Hospital, Ghent
Frequently Asked Questions
Who can join the NCT04627818 clinical trial?
This trial is open to female participants only, up to 45 Years, studying Mullerian Anomaly of Uterus, Nec. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04627818 currently recruiting?
Yes, NCT04627818 is actively recruiting participants. Contact the research team at eline.meireson@uzgent.be for enrollment information.
Where is the NCT04627818 trial being conducted?
This trial is being conducted at Ghent, Belgium.
Who is sponsoring the NCT04627818 clinical trial?
NCT04627818 is sponsored by University Hospital, Ghent. The principal investigator is Tjalina Hamerlynck at University Hospital, Ghent. The trial plans to enroll 1,500 participants.